Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Submissions
(SUB)
last updated: 14 Aug 2025
Niger
SYNTHETIC BIOLOGY: A STRATEGIC LEVER FOR BIODIVERSITY CONSERVATION AND SUSTAINABLE DEVELOPMENT IN NIGER
EN
04 Aug 2025
SCBD/CPU/JL/WM/AMC/MW/92264
(2025-088)
Extension of deadline: Submissions of information on synthetic biology to support the preparation of the thematic action plan in the context of synthetic biology and the work of the Ad Hoc Technical Expert Group on Synthetic Biology
SCBD/CPU/WM/AMC/MW/92264
(2025-065)
Submissions of information on synthetic biology to support the preparation of the thematic action plan in the context of synthetic biology and the work of the Ad Hoc Technical Expert Group on Synthetic Biology
-
CHM-NFP-NE-264405-5 National Focal Points Dr. Mahamadou Alhassane
- Biologie Synthetique contribution du Niger English version.pdf ( Synthetic Biology, Niger, National Contribution, CBD, Cartagena Protocol, GEF-9, Biosafety, Biotechnology, Policy Document, English Translation ) [ English ]
Any other relevant information
This submission has been developed in alignment with the national biosafety strategy (2020–2030), the priorities identified under GEF-9, and the decisions adopted at COP-15 and COP-16 of the Convention on Biological Diversity. It reflects inclusive national consultations involving key stakeholders from regulatory bodies, scientific institutions, customs authorities, and civil society. Supporting documents include the completed GEF-9 funding needs questionnaire, the national roadmap, and stakeholder participation records.
This submission has been developed in alignment with the national biosafety strategy (2020–2030), the priorities identified under GEF-9, and the decisions adopted at COP-15 and COP-16 of the Convention on Biological Diversity. It reflects inclusive national consultations involving key stakeholders from regulatory bodies, scientific institutions, customs authorities, and civil society. Supporting documents include the completed GEF-9 funding needs questionnaire, the national roadmap, and stakeholder participation records.